The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/21964
StudyName: Eligibility Multiple Myeloma NCT00866138
Date of export from the portal: 02.07.2020
Date of Upload / last change: 10.05.2017
License: Creative Commons BY 4.0

----

Description: 
A Phase 2 Study to Evaluate Efficacy and Safety of Masitinib in Patients With Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3; ODM derived from: https://clinicaltrials.gov/show/NCT00866138
